Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.
about
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the futureAllergens are not pathogens: why immunization against allergy differs from vaccination against infectious diseasesAllergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific ImmunotherapyNew vaccines for Mammalian allergy using molecular approachesFood allergies: the basicsSublingual immunotherapy: World Allergy Organization position paper 2013 update.Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.Perinatal Immunization With Vaccine-Grade Listeria monocytogenes Provides Protection Against Murine Th2 Airway InflammationGlycoproteomic analysis of seven major allergenic proteins reveals novel post-translational modifications.Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.T Cell Epitope-Containing Domains of Ragweed Amb a 1 and Mugwort Art v 6 Modulate Immunologic Responses in Humans and MicePEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccinationAutologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: Long-Term Changes of Clinical Severity and Laboratory ParametersCell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy.Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergyThe influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine.Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis.Kimura's disease or IgG4-related disease? A case-based review.Preventive capacity of allergen immunotherapy on the natural history of allergyImmunotherapy in allergy and cellular tests: state of art.Phase II drugs under investigation for allergic conjunctivitis.Advances in patent applications related to allergen immunotherapy.Allergen extracts and recombinant proteins: comparison of efficiency of in vitro allergy diagnostics using multiplex assay on a biological microchip.Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.Molecular chimerism in IgE-mediated allergy: B-and T-cell tolerance toward highly immunogenic exogenous antigens.Clustering of conformational IgE epitopes on the major dog allergen Can f 1.Trends in Specific Immunotherapy for Allergic Rhinitis: A Survey of Chinese ENT Specialists.Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice.Detection of IgE Reactivity to a Handful of Allergen Molecules in Early Childhood Predicts Respiratory Allergy in Adolescence.Delayed Immunomodulatory Effect of Cow Milk-Free Diet in Ménière's Disease.Cutaneous vaccination with coated microneedles prevents development of airway allergy.Mouse Models Applied to the Research of Pharmacological Treatments in Asthma.Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice.A modified, hypoallergenic variant of the Ricinus communis Ric c1 protein retains biological activity.Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches.Severe asthma and allergy: mechanisms, diagnostics and treatment
P2860
Q26768511-2BF1CEF4-2CB2-4D24-855A-EA0F14F58303Q26828969-9508655E-4350-48CC-A925-D069E02E9B94Q26852113-705E8AF5-1BD3-41EF-9974-3E6453046D10Q26998820-B81BDA4D-3F00-497C-A522-EF0A601ACCA1Q27011839-957AD5E2-2ECB-4E2D-A5EA-221C5989935FQ30440195-EF668B7F-703E-4A98-928D-8F37AA1B7A8FQ33684408-16E519F4-CF58-4D9A-BB15-C4F707063BB8Q33831595-22D5D7AF-44C5-4069-8862-12C69C7312F3Q34884157-5596161E-DA7B-4A59-ABA9-354E5122FE81Q35949214-EAC1E07D-45FD-48C0-A05E-C2F1DA3FBBF2Q36247634-F09E469A-E522-4705-A579-D31FC75E986CQ36509826-1A1F8B53-59D3-42FB-B808-86E4343813EBQ36859385-E05E6FA2-560F-4ED4-845A-10ED10CC040EQ37008459-9D276785-E4B8-4258-B1E5-93C64D7B985EQ37309704-D3F7A6EA-5C61-435E-BE73-AC815FEC0B80Q37502385-49AD8F0B-5008-430D-A84C-CB4336883C70Q38154958-6398B850-9DF8-4CC0-9339-B2367BC97C7EQ38172431-DE61479E-29AA-4BC4-9147-48B8603B78E3Q38176377-6E90EF83-D5A6-4B40-899F-B16BBF50EF30Q38203380-01F751C1-B520-4DE0-B817-E4BC0578798CQ38234039-270C7002-31DB-4892-A78C-BB02878D544CQ38787402-724B8003-F794-4ACD-9EAD-2F080B96284CQ38959808-73FB3945-9BCE-4630-83E1-DE94293B8835Q40087434-81CAADD7-4360-474F-941A-D013E981CF10Q40730015-F321C2AC-54F3-4C67-A271-C7DA68BB5ACFQ42252694-83A7935E-899E-4011-89C1-6E5675FCFF69Q42716940-E3A2FF7B-FBD0-403C-A322-05C871ECFD74Q43194033-1ED2B2AC-EA0F-4D22-8DB2-CFAF0135D938Q47340806-9B12B027-BA87-4781-B355-93689D44D400Q47583797-A9BE5540-1D3B-4B5A-AAAF-74130452F774Q47778162-34614271-59C0-440E-85B7-C7F4AA4AB5C5Q51703539-18E4DD27-CC63-4497-9D07-27C773E9F2B9Q52313895-9E45D93C-A88C-4A43-9421-0EA343173352Q52695058-96D28592-9CCF-4776-ADA2-6E2F2A27C5A2Q55436442-0DD00666-6A0F-4A6D-B15C-0E566CAE2ED3Q57266971-73648ED2-1360-45FA-845D-C7A6858597CD
P2860
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.
@en
type
label
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.
@en
prefLabel
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.
@en
P2093
P2860
P1476
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2012.02556.X
P407
P577
2012-08-01T00:00:00Z